Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 2, 2006, Pages 326-330

  Berild, Dag ^a   Mohseni, Atefeh ^a   Diep, Lien My ^a   Jensenius, Mogens ^a   Ringertz, Signe Holta ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bacteraemia; Guidelines; Resistance; Septicaemia; Therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DICLOXACILLIN; DOXYCYCLINE; FUSIDIC ACID; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL DECISION MAKING; DRUG COST; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG USE; EMPIRICISM; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PRACTICE GUIDELINE; PRESCRIPTION; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG COSTS; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; GUIDELINES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NORWAY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 31544436382     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki463     Document Type: Article

References (18)

1. Hanon FX, Monnet DL, Sorensen TL et al. Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis 2002; 34: 520-8.
2. Arbo MD, Snydman DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994; 154: 2641-5.
3. Cunney RJ, McNamara EB, Alansari N et al. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia. J Clin Pathol 1997; 50: 1010-12.
4. Campo L, Mylotte JM. Use of microbiology reports by physicians in prescribing antimicrobial agents. Am J Med Sci 1988; 296: 392-8.
5. Dunagan WC, Woodward RS, Medoff G et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989; 87: 253-9.
6. Dunagan WC, Woodward RS, Medoff G et al. Antibiotic misuse in two clinical situations: Positive blood culture and administration of aminoglycosides. Rev Infect Dis 1991; 13: 405-12.
7. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J Infect 1997; 35: 283-88.
8. Maki DG, Schuna AA. A study of antimicrobial misuse in a university hospital. Am J Med Sci 1978; 275: 271-82.
9. Berild D, Ringertz SH, Lelek M et al. Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital. Scand J Infect Dis 2001; 33: 63-7.
10. Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: Report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis 2002; 34: 56-60.
11. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95: 78-82.
12. Bryan CS. Blood cultures for community-acquired pneumonia: No place to skimp! Chest 1999; 116: 1153-5.
13. Kumarasamy Y, Cadwgan T, Gillanders IA et al. Optimizing antibiotic therapy-the Aberdeen experience. Clin Microbiol Infect 2003; 9: 406-11.
14. Herchline T, Gros S. Improving clinical outcome in bacteremia. J Eval Clin Pract 1998; 4: 191-5.
15. Olesen B, Kolmos HJ, Orskov F et al. Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990. Scand J Infect Dis 1995; 27: 253-7.
16. Zaragoza R, Artero A, Camarena JJ et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003; 9: 412-18.
17. Howard D, Cordell R, McGowan JE, Jr et al. Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis 2001; 33: 1573-8.
18. Tumidge J. Impact of antibiotic resistance on the treatment of sepsis. Scand J Infect Dis 2003; 35: 677-82.